Keiji Wakabayashi Selected Research

Keiji Wakabayashi Research Topics

Disease

61	Carcinogenesis 12/2023 - 01/2002
59	Neoplasms (Cancer) 12/2023 - 01/2000
22	Colonic Neoplasms (Colon Cancer) 08/2017 - 01/2002
19	Adenocarcinoma 01/2022 - 04/2003
18	Colorectal Neoplasms (Colorectal Cancer) 02/2023 - 03/2006
18	Intestinal Polyps 01/2019 - 09/2002
16	Polyps 01/2022 - 09/2002
12	Inflammation (Inflammations) 12/2023 - 01/2000
11	Adenoma (Adenomas) 01/2022 - 06/2004
10	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022 - 07/2003
9	Aberrant Crypt Foci 08/2017 - 01/2002
9	Hyperlipidemias (Hyperlipidemia) 02/2011 - 09/2003
8	Carcinoma (Carcinomatosis) 01/2021 - 01/2003
8	Body Weight (Weight, Body) 01/2014 - 06/2005
6	Pancreatic Neoplasms (Pancreatic Cancer) 05/2012 - 08/2007
4	Asthma (Bronchial Asthma) 01/2020 - 08/2018
4	Obesity 01/2016 - 08/2011
4	Gastritis 09/2013 - 02/2002
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2009 - 03/2006
3	Colitis 08/2007 - 01/2006
2	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2012
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2020
2	Allergic Rhinitis 01/2020 - 01/2020
2	Hypertriglyceridemia 01/2016 - 04/2008
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2002
2	Ulcer 02/2013 - 06/2011
2	Infections 01/2012 - 02/2003
2	Lung Neoplasms (Lung Cancer) 09/2009 - 02/2008

Drug/Important Bio-Agent (IBA)

16	AzoxymethaneIBA 08/2017 - 01/2002
12	Messenger RNA (mRNA)IBA 05/2017 - 01/2002
11	CarcinogensIBA 02/2020 - 01/2002
11	ProstaglandinsIBA 03/2008 - 01/2000
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2002
10	LipidsIBA 11/2011 - 03/2003
9	Triglycerides (Triacylglycerol)IBA 01/2012 - 09/2003
8	colibactinIBA 02/2023 - 01/2019
8	DNA AdductsIBA 01/2021 - 01/2003
8	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2017 - 01/2002
8	Drinking WaterIBA 01/2014 - 10/2003
8	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2011 - 03/2002
7	EnzymesIBA 01/2022 - 01/2000
7	Dextrans (Dextran)FDA Link 01/2014 - 01/2005
7	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2014 - 01/2005
7	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2008 - 01/2000
7	beta CateninIBA 10/2007 - 06/2004
7	Prostaglandins EIBA 03/2007 - 01/2002
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 02/2013
6	MutagensIBA 02/2023 - 04/2004
6	AminesIBA 01/2022 - 10/2007
6	nitrosobis(2-oxopropyl)amine (NBOP)IBA 05/2012 - 04/2003
6	PPAR gammaIBA 01/2012 - 09/2003
6	Pioglitazone (Actos)FDA Link 01/2012 - 09/2003
6	nimesulide (Aulin)IBA 03/2006 - 01/2002
6	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2006 - 01/2002
5	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 02/2020 - 01/2002
5	LigandsIBA 01/2012 - 09/2003
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2012 - 09/2003
5	AdipokinesIBA 01/2012 - 04/2008
4	QuinoxalinesIBA 02/2020 - 02/2008
4	EndotoxinsIBA 01/2020 - 08/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2004
4	PPAR alphaIBA 10/2007 - 09/2003
3	CateninsIBA 12/2023 - 01/2014
3	2-toluidine (o-toluidine)IBA 12/2020 - 01/2020
3	benzocycloheptapyridineIBA 02/2020 - 01/2005
3	LeptinIBA 01/2016 - 08/2011
3	Indomethacin (Indometacin)FDA LinkGeneric 11/2012 - 04/2004
3	Urethane (Ethyl Carbamate)IBA 11/2012 - 02/2008
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 12/2009 - 02/2005
3	7- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA 08/2008 - 03/2006
3	Protein Isoforms (Isoforms)IBA 03/2008 - 01/2000
3	Codon (Codons)IBA 02/2008 - 06/2004
3	Dinoprostone (PGE2)FDA Link 03/2007 - 05/2003
3	ONO 8711IBA 03/2007 - 07/2003
3	mofezolacIBA 10/2006 - 09/2002
3	Cyclooxygenase 1IBA 10/2006 - 09/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2006 - 10/2003
3	Bromodeoxyuridine (BrdU)IBA 05/2005 - 09/2002
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2003 - 01/2002
2	PolyketidesIBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	AcetyltransferasesIBA 01/2021 - 01/2020
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2006
2	PowdersIBA 05/2020 - 06/2011
2	aniline (aniline hydrobromide)IBA 02/2020 - 03/2002
2	Particulate MatterIBA 01/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2017 - 02/2008
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2017 - 05/2017
2	Interleukin-6 (Interleukin 6)IBA 05/2017 - 02/2016
2	CytokinesIBA 01/2016 - 06/2011
2	Insulin (Novolin)FDA Link 01/2016 - 01/2012
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016 - 01/2000
2	AcidsIBA 05/2012 - 09/2008
2	Plasminogen Activators (Plasminogen Activator)IBA 06/2011 - 04/2008
2	DiglyceridesIBA 03/2009 - 06/2007

Therapy/Procedure

9	Chemoprevention 12/2021 - 07/2003
3	Colectomy 01/2021 - 01/2016
2	Intraperitoneal Injections 11/2012 - 06/2011
2	Injections 06/2011 - 05/2003